AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 99 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,615 | +24.6% | 4,926 | 0.0% | 0.00% | – |
| Q2 2023 | $4,507 | -96.9% | 4,926 | -97.6% | 0.00% | – |
| Q1 2022 | $147,000 | -69.2% | 205,062 | -2.9% | 0.00% | -100.0% |
| Q4 2021 | $477,000 | -21.3% | 211,115 | +0.4% | 0.00% | 0.0% |
| Q3 2021 | $606,000 | -21.2% | 210,310 | +3.6% | 0.00% | 0.0% |
| Q2 2021 | $769,000 | +30.3% | 202,959 | +16.5% | 0.00% | 0.0% |
| Q1 2021 | $590,000 | +11.5% | 174,241 | -7.8% | 0.00% | 0.0% |
| Q4 2020 | $529,000 | +19.7% | 189,081 | +7.4% | 0.00% | 0.0% |
| Q3 2020 | $442,000 | -84.4% | 176,016 | -15.9% | 0.00% | -80.0% |
| Q2 2020 | $2,841,000 | +74.6% | 209,199 | -2.6% | 0.01% | +66.7% |
| Q1 2020 | $1,627,000 | +40.0% | 214,691 | +16.7% | 0.00% | +50.0% |
| Q4 2019 | $1,162,000 | +67.2% | 183,902 | +3.7% | 0.00% | +100.0% |
| Q3 2019 | $695,000 | -10.9% | 177,258 | +10.0% | 0.00% | 0.0% |
| Q2 2019 | $780,000 | -15.2% | 161,199 | +43.5% | 0.00% | -50.0% |
| Q1 2019 | $920,000 | +37.1% | 112,300 | -7.5% | 0.00% | +100.0% |
| Q4 2018 | $671,000 | +68.2% | 121,397 | +168.4% | 0.00% | 0.0% |
| Q3 2018 | $399,000 | -16.2% | 45,234 | -5.1% | 0.00% | 0.0% |
| Q2 2018 | $476,000 | +21.7% | 47,647 | +16.1% | 0.00% | 0.0% |
| Q1 2018 | $391,000 | -35.5% | 41,042 | +0.7% | 0.00% | 0.0% |
| Q4 2017 | $606,000 | -31.2% | 40,772 | -8.9% | 0.00% | -50.0% |
| Q3 2017 | $881,000 | +47.8% | 44,765 | +7.8% | 0.00% | +100.0% |
| Q2 2017 | $596,000 | +58.1% | 41,510 | +1.3% | 0.00% | 0.0% |
| Q1 2017 | $377,000 | -8.9% | 40,992 | +3.2% | 0.00% | 0.0% |
| Q4 2016 | $414,000 | -1.7% | 39,726 | -14.6% | 0.00% | 0.0% |
| Q3 2016 | $421,000 | +22.7% | 46,541 | +1.5% | 0.00% | 0.0% |
| Q2 2016 | $343,000 | -15.3% | 45,831 | +2.1% | 0.00% | 0.0% |
| Q1 2016 | $405,000 | -4.5% | 44,908 | +36.9% | 0.00% | 0.0% |
| Q4 2015 | $424,000 | +38.1% | 32,798 | +3.2% | 0.00% | 0.0% |
| Q3 2015 | $307,000 | -0.3% | 31,788 | +6.2% | 0.00% | 0.0% |
| Q2 2015 | $308,000 | – | 29,940 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $13,027,000 | 5.13% |
| Orchard Capital Management, LLC | 857,138 | $2,400,000 | 1.02% |
| Nantahala Capital Management | 7,040,487 | $19,713,000 | 0.61% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 209,040 | $585,000 | 0.18% |
| Woodline Partners LP | 2,382,522 | $6,671,000 | 0.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,546,169 | $4,329,000 | 0.15% |
| Virtus ETF Advisers LLC | 92,771 | $260,000 | 0.11% |
| Jump Financial, LLC | 155,583 | $435,000 | 0.07% |
| GSA CAPITAL PARTNERS LLP | 128,626 | $360,000 | 0.06% |
| Anson Funds Management LP | 95,342 | $267,000 | 0.05% |